In the News

Le Dauphine Libere
National Institute for Health Research
Lokalzeit aus Bonn (March 26, 2015)
9 News (March 9, 2015)
WDRB (March 1, 2015)
The Courier-Journal (Feb 25, 2015)
Clinica (Feb 2, 2015)
U of L Today (Jan 28, 2015)

Press Releases

REDWOOD CITY, Calif. – December 20, 2017 – Pulmonx® Corp. today announced that the UK's National Institute for Health and Care Excellence (NICE) has updated its guidance for endobronchial valves used to treat severe emphysema, an advanced form of chronic obstructive pulmonary disease (COPD), and now...

Read more

Washington DC and Redwood City, Calif. – May 23, 2017 – Pulmonx, Inc. today announced the results of two multi-center, randomized clinical trials showing clinically meaningful improvements in lung function after treatment with the Zephyr® Endobronchial Valve (EBV) in emphysema patients without...

Read more
CAUTION: The Zephyr Endobronchial Valve is an investigational device in the US, limited by US law to investigational use.
US / new visitor